- Medicinal Maggot Application and Maggot Therapy Dressing Technology
- Ronald A. Sherman (author)
Export Metadata
| Title |
|
|---|---|
| Contributor | Ronald A. Sherman (author) |
| DOI | https://doi.org/10.11647/obp.0300.05 |
| Landing page | https://www.openbookpublishers.com/books/10.11647/obp.0300/chapters/10.11647/obp.0300.05 |
| License | https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright | Ronald A. Sherman |
| Publisher | Open Book Publishers |
| Publication place | Cambridge, UK |
| Published on | 2022-07-20 |
| Long abstract | Maggot therapy dressings are intended to keep maggots on the wound during treatment. Some therapists make their own dressings, others use commercially produced dressings, and many use both, depending on their patients’ wounds. There are two basic designs for maggot dressings. Maggot confinement dressings confine the maggots to the wound bed and allow them complete access to the wound, while maggot containment dressings totally contain the maggots within a net bag that facilitates easy handling but does not allow full access to the wound. This chapter describes the basic principles and goals of the ideal maggot dressing, and provides examples of how that ideal dressing can be achieved. |
| Page range | pp. 79–96 |
| Language | English (Original) |
Contributors
Ronald A. Sherman
(author)Ronald A. Sherman retired from the University of California, Irvine in 2008 in order to devote his time to teaching, research, and patient-care activities using medicinal animals. He has studied maggot therapy for over forty years, and began the first controlled clinical trials of maggot therapy in 1990. In 2004, the Medical Maggots™ which he developed at the University of California became the first living organism to be granted marketing clearance by the U.S. Food and Drug Administration as a medical device. He holds degrees in entomology, medicine, and clinical tropical medicine. Ronald Sherman is Director of the BioTherapeutics, Education and Research (BTER) Foundation, which develops educational and research programmes in biotherapy, and he is Co-Founder and Laboratory Director of Monarch Labs, which produces medicinal animals in North America. He does not accept financial support for either of these positions, nor for any of his maggot therapy teaching or research. Instead, he earns his living working in an unrelated field, as an HIV/AIDS physician for the county health department. His wife, however, is paid a salary for working in the maggot lab, day and night.
References
- 1. Fine, A. and H. Alexander, Maggot Therapy: Technique and Clinical Application. The Journal of Bone and Joint Surgery, 1934. 16(3): pp. 572–582.
- 2. Sherman, R.A., A New Dressing Design for Use with Maggot Therapy. Plastic and Reconstructive Surgery, 1997. 100(2): pp. 451–456, https://doi.org/10.1097/00006534-199708000-00029. (opens in new tab)
- 3. Sherman, R.A., J.M. Tran, and R. Sullivan, Maggot Therapy for Venous Stasis Ulcers. Archives of Dermatology, 1996. 132(3): pp. 254–256 https://jamanetwork.com/journals/jamadermatology/fullarticle/vol/132/pg/254.
- 4. Grassberger, M. and W. Fleischmann, The Biobag — A New Device for the Application of Medicinal Maggots. Dermatology, 2002. 204(4): p. 306, https://doi.org/10.1159/000063369. (opens in new tab)
- 5. Dumville, J.C., et al., Larval Therapy for Leg Ulcers (VenUS II): Randomised Controlled Trial. BMJ, 2009. 338(7702): pp. 1047–1050, https://doi.org/10.1136/bmj.b773. (opens in new tab)
- 6. Steenvoorde, P., T. Budding, and J. Oskam, Determining Pain Levels in Patients Treated with Maggot Debridement Therapy. Journal of Wound Care, 2005. 14(10): pp. 485–488, https://doi.org/10.12968/jowc.2005.14.10.26846. (opens in new tab)
- 7. Steenvoorde, P., C.E. Jacobi, and J. Oskam, Maggot Debridement Therapy: Free-Range or Contained? An in-vivo Study. Advances in Skin & Wound Care, 2005. 18(8): pp. 430–435, https://doi.org/10.1097/00129334-200510000-00010. (opens in new tab)
- 8. Steenvoorde, P., et al., Maggot Debridement Therapy of Infected Ulcers: Patient and Wound Factors Influencing Outcome — A Study on 101 Patients with 117 Wounds. Annals of the Royal College of Surgeons of England, 2007. 89(6): pp. 596–602, https://doi.org/10.1308/003588407x205404. (opens in new tab)
- 9. Stadler, F., Packaging Technology, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 349–362, https://doi.org/10.11647/OBP.0300.16.(opens in new tab)
- 10. DeFazio, M.V., et al., Home Improvement in Maggot Therapy: Designing a Simple, Cost-Effective, Closed-System Habitat to Facilitate Biodébridement of Complex Distal Lower Extremity Wounds. Plastic and Reconstructive Surgery, 2015. 136(5): pp. 722e-723e, https://doi.org/10.1097/prs.0000000000001685. (opens in new tab)
- 11. Felder, J.M., 3rd, et al., Increasing the Options for Management of Large and Complex Chronic Wounds with a Scalable, Closed-system Dressing for Maggot Therapy. Journal of Burn Care & Research, 2012. 33(3): pp. e169–175, https://doi.org/10.1097/BCR.0b013e318233570d. (opens in new tab)
- 12. All Wales Tissue Viability Nurse Forum. The All Wales Guidance for the Use of Larval Debridement Therapy (LDT). 2013. https://www.wounds-uk.com/download/resource/5850.
- 13. Sherman, R., Indications, Contraindications, Interactions, and Side-effects of Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 63–78, https://doi.org/10.11647/OBP.0300.04.(opens in new tab)
- 14. Andersen, A.S., et al., Quorum-sensing-regulated Virulence Factors in Pseudomonas aeruginosa Are Toxic to Lucilia sericata Maggots. Microbiology (Society for General Microbiology), 2010. 156(2): pp. 400–407, https://doi.org/10.1099/mic.0.032730-0. (opens in new tab)
- 15. Sherman, R.A. and K.J. Shimoda, Presurgical Maggot Debridement of Soft Tissue Wounds Is Associated with Decreased Rates of Postoperative Infection. Clinical Infectious Diseases, 2004. 39(7): pp. 1067–1070, https://doi.org/10.1086/423806.(opens in new tab)
